Amgen Rockville Stock Price, News & Analysis (NASDAQ:MITI)

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

About Amgen Rockville (NASDAQ:MITI)

Amgen Rockville logoDesigns and develops antibody-based drugs for treatment of cancer. The Company is a biotechnology company with a focus on the development of antibody-based products for cancer and inflammatory and autoimmune diseases. Micromet has established a drug development platform based on its BiTE technology, a drug format that leverages the cytotoxic potential of T cells.

Receive MITI News and Ratings via Email

Sign-up to receive the latest news and ratings for MITI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding SharesN/A

Amgen Rockville (NASDAQ:MITI) Frequently Asked Questions

What is Amgen Rockville's stock symbol?

Amgen Rockville trades on the NASDAQ under the ticker symbol "MITI."

Who are some of Amgen Rockville's key competitors?

How do I buy Amgen Rockville stock?

Shares of Amgen Rockville can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Amgen Rockville?

Amgen Rockville's mailing address is 9201 Corporate Blvd Ste 400, ROCKVILLE, MD 20850-7209, United States. The biotechnology company can be reached via phone at +1-240-7521420.

MarketBeat Community Rating for Amgen Rockville (MITI)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  58 (Vote Outperform)
Underperform Votes:  56 (Vote Underperform)
Total Votes:  114
MarketBeat's community ratings are surveys of what our community members think about Amgen Rockville and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Amgen Rockville (NASDAQ:MITI) Analyst Ratings History

No equities research coverage for this company has been tracked by MarketBeat


Amgen Rockville (NASDAQ:MITI) Earnings History and Estimates Chart

Earnings by Quarter for Amgen Rockville (NASDAQ:MITI)

Amgen Rockville (NASDAQ MITI) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/8/2011($0.23)($0.17)ViewN/AView Earnings Details
8/4/2011($0.21)($0.19)ViewN/AView Earnings Details
5/10/2011($0.17)($0.19)ViewN/AView Earnings Details
3/3/2011($0.15)($0.17)ViewN/AView Earnings Details
11/9/2010Q3 2010($0.19)($0.12)ViewN/AView Earnings Details
8/5/2010Q2 2010($0.17)($0.04)ViewN/AView Earnings Details
5/5/2010Q1 2010($0.17)($0.15)ViewN/AView Earnings Details
3/4/2010Q4 2009($0.18)($0.34)ViewN/AView Earnings Details
11/5/2009Q3 2009($0.14)($0.22)ViewN/AView Earnings Details
8/6/2009Q2 2009($0.14)($0.15)ViewN/AView Earnings Details
5/6/2009Q1 2009($0.10)($0.09)ViewN/AView Earnings Details
3/12/2009Q4 2008($0.16)($0.12)ViewN/AView Earnings Details
11/6/2008Q3 2008($0.14)($0.15)ViewN/AView Earnings Details
8/7/2008Q2 2008($0.14)($0.21)ViewN/AView Earnings Details
5/8/2008Q1 2008($0.13)($0.14)ViewN/AView Earnings Details
3/13/2008Q4 2007($0.13)($0.09)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Amgen Rockville (NASDAQ:MITI) Earnings Estimates

No earnings estimates for this company have been tracked by


Dividend History for Amgen Rockville (NASDAQ:MITI)

No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Amgen Rockville (NASDAQ MITI)

No insider trades for this company have been tracked by


Amgen Rockville (NASDAQ MITI) News Headlines

No headlines for this company have been tracked by

SEC Filings

Amgen Rockville (NASDAQ:MITI) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Amgen Rockville (NASDAQ:MITI) Income Statement, Balance Sheet and Cash Flow Statement


Amgen Rockville (NASDAQ MITI) Stock Chart for Saturday, February, 24, 2018

Loading chart…

This page was last updated on 2/24/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.